Unlike other solid or hematologic malignancies, Chronic Myeloid Leukemia (CML) is characterized by a single pathogenic alteration: the BCR-ABL1 chimeric oncogene (1–6). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.